Prophylactic efficiency and safety of anaferon (pediatric formulation) in children aging 1 month to 4 years, including sickly children, was proven. The use of the preparation in children reduced the incidence of acute respiratory infections, alleviated the course of the disease, and decreased the incidence of detection of viral antigens in nasal meatuses.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
V. D. Belyakov, G. A. Semenenko, and M. K. Shraga, Introduction into Epidemiology of Infectious and Non-Infectious Diseases in Humans [in Russian], Moscow (2001).
V. G. Zilov, K. V. Sudakov, O. I. Epshtein, Elements of Information Biology and Medicine [in Russian], Moscow (2001).
G. A. Samsygina, Practika Pediatra, No. 12, 40–44 (2005).
E. Yu. Sherstoboev, N. V. Masnaya, A. A. Churin, et al., Byull. Eksp. Biol. Med., Suppl. 3, 37–39 (2001).
Author information
Authors and Affiliations
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 148, Suppl. 1, pp. 18–21, August, 2009
Rights and permissions
About this article
Cite this article
Erman, E.S., Osidak, L.V., Sukhovetskaya, V.F. et al. Efficiency of Interferon Inductor Anaferon (Pediatric Formulation) in Prophylaxis of Acute Respiratory Infections in Sickly Children. Bull Exp Biol Med 148, 270 (2009). https://doi.org/10.1007/s10517-009-0705-x
Received:
Published:
DOI: https://doi.org/10.1007/s10517-009-0705-x